Copyright Reports & Markets. All rights reserved.

Global Peptic Ulcer Drugs Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Peptic Ulcer Drugs Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Peptic Ulcer Drugs Market Size Growth Rate by Type
    • 1.4.2 Proton Pump Inhibitors
    • 1.4.3 Antacids
    • 1.2.4 H2-Antagonists
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Peptic Ulcer Drugs Market Size Growth Rate by Application
    • 1.3.2 Hospital and Clinic
    • 1.3.3 Drugstore
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Peptic Ulcer Drugs Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Peptic Ulcer Drugs Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Peptic Ulcer Drugs Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Peptic Ulcer Drugs Regions by Sales
    • 2.4.1 Global Top Peptic Ulcer Drugs Regions by Sales (2016-2021)
    • 2.4.2 Global Top Peptic Ulcer Drugs Regions by Sales (2022-2027)
  • 2.5 Global Top Peptic Ulcer Drugs Regions by Revenue
    • 2.5.1 Global Top Peptic Ulcer Drugs Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Peptic Ulcer Drugs Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Peptic Ulcer Drugs Sales by Manufacturers
    • 3.1.1 Global Top Peptic Ulcer Drugs Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Peptic Ulcer Drugs Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Peptic Ulcer Drugs Sales in 2020
  • 3.2 Global Peptic Ulcer Drugs Revenue by Manufacturers
    • 3.2.1 Global Top Peptic Ulcer Drugs Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Peptic Ulcer Drugs Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Peptic Ulcer Drugs Revenue in 2020
  • 3.3 Global Peptic Ulcer Drugs Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Peptic Ulcer Drugs Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Peptic Ulcer Drugs Sales by Type
    • 4.1.1 Global Peptic Ulcer Drugs Historical Sales by Type (2016-2021)
    • 4.1.2 Global Peptic Ulcer Drugs Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Peptic Ulcer Drugs Sales Market Share by Type (2016-2027)
  • 4.2 Global Peptic Ulcer Drugs Revenue by Type
    • 4.2.1 Global Peptic Ulcer Drugs Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Peptic Ulcer Drugs Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Peptic Ulcer Drugs Revenue Market Share by Type (2016-2027)
  • 4.3 Global Peptic Ulcer Drugs Price by Type
    • 4.3.1 Global Peptic Ulcer Drugs Price by Type (2016-2021)
    • 4.3.2 Global Peptic Ulcer Drugs Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Peptic Ulcer Drugs Sales by Application
    • 5.1.1 Global Peptic Ulcer Drugs Historical Sales by Application (2016-2021)
    • 5.1.2 Global Peptic Ulcer Drugs Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Peptic Ulcer Drugs Sales Market Share by Application (2016-2027)
  • 5.2 Global Peptic Ulcer Drugs Revenue by Application
    • 5.2.1 Global Peptic Ulcer Drugs Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Peptic Ulcer Drugs Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Peptic Ulcer Drugs Revenue Market Share by Application (2016-2027)
  • 5.3 Global Peptic Ulcer Drugs Price by Application
    • 5.3.1 Global Peptic Ulcer Drugs Price by Application (2016-2021)
    • 5.3.2 Global Peptic Ulcer Drugs Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Peptic Ulcer Drugs Market Size by Type
    • 6.1.1 North America Peptic Ulcer Drugs Sales by Type (2016-2027)
    • 6.1.2 North America Peptic Ulcer Drugs Revenue by Type (2016-2027)
  • 6.2 North America Peptic Ulcer Drugs Market Size by Application
    • 6.2.1 North America Peptic Ulcer Drugs Sales by Application (2016-2027)
    • 6.2.2 North America Peptic Ulcer Drugs Revenue by Application (2016-2027)
  • 6.3 North America Peptic Ulcer Drugs Market Size by Country
    • 6.3.1 North America Peptic Ulcer Drugs Sales by Country (2016-2027)
    • 6.3.2 North America Peptic Ulcer Drugs Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Peptic Ulcer Drugs Market Size by Type
    • 7.1.1 Europe Peptic Ulcer Drugs Sales by Type (2017-2027)
    • 7.1.2 Europe Peptic Ulcer Drugs Revenue by Type (2017-2027)
  • 7.2 Europe Peptic Ulcer Drugs Market Size by Application
    • 7.2.1 Europe Peptic Ulcer Drugs Sales by Application (2017-2027)
    • 7.2.2 Europe Peptic Ulcer Drugs Revenue by Application (2017-2027)
  • 7.3 Europe Peptic Ulcer Drugs Market Size by Country
    • 7.3.1 Europe Peptic Ulcer Drugs Sales by Country (2017-2027)
    • 7.3.2 Europe Peptic Ulcer Drugs Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Peptic Ulcer Drugs Market Size by Type
    • 8.1.1 Asia Pacific Peptic Ulcer Drugs Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Peptic Ulcer Drugs Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Peptic Ulcer Drugs Market Size by Application
    • 8.2.1 Asia Pacific Peptic Ulcer Drugs Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Peptic Ulcer Drugs Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Peptic Ulcer Drugs Market Size by Region
    • 8.3.1 Asia Pacific Peptic Ulcer Drugs Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Peptic Ulcer Drugs Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Peptic Ulcer Drugs Market Size by Type
    • 9.1.1 Latin America Peptic Ulcer Drugs Sales by Type (2019-2027)
    • 9.1.2 Latin America Peptic Ulcer Drugs Revenue by Type (2019-2027)
  • 9.2 Latin America Peptic Ulcer Drugs Market Size by Application
    • 9.2.1 Latin America Peptic Ulcer Drugs Sales by Application (2019-2027)
    • 9.2.2 Latin America Peptic Ulcer Drugs Revenue by Application (2019-2027)
  • 9.3 Latin America Peptic Ulcer Drugs Market Size by Country
    • 9.3.1 Latin America Peptic Ulcer Drugs Sales by Country (2019-2027)
    • 9.3.2 Latin America Peptic Ulcer Drugs Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Peptic Ulcer Drugs Market Size by Type
    • 6.1.1 Middle East and Africa Peptic Ulcer Drugs Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Peptic Ulcer Drugs Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Peptic Ulcer Drugs Market Size by Application
    • 6.2.1 Middle East and Africa Peptic Ulcer Drugs Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Peptic Ulcer Drugs Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Peptic Ulcer Drugs Market Size by Country
    • 6.3.1 Middle East and Africa Peptic Ulcer Drugs Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Peptic Ulcer Drugs Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Takeda Pharmaceutical
    • 11.1.1 Takeda Pharmaceutical Corporation Information
    • 11.1.2 Takeda Pharmaceutical Overview
    • 11.1.3 Takeda Pharmaceutical Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Takeda Pharmaceutical Peptic Ulcer Drugs Product Description
    • 11.1.5 Takeda Pharmaceutical Related Developments
  • 11.2 AstraZeneca
    • 11.2.1 AstraZeneca Corporation Information
    • 11.2.2 AstraZeneca Overview
    • 11.2.3 AstraZeneca Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 AstraZeneca Peptic Ulcer Drugs Product Description
    • 11.2.5 AstraZeneca Related Developments
  • 11.3 Pfizer
    • 11.3.1 Pfizer Corporation Information
    • 11.3.2 Pfizer Overview
    • 11.3.3 Pfizer Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Pfizer Peptic Ulcer Drugs Product Description
    • 11.3.5 Pfizer Related Developments
  • 11.4 Teva Pharmaceuticals
    • 11.4.1 Teva Pharmaceuticals Corporation Information
    • 11.4.2 Teva Pharmaceuticals Overview
    • 11.4.3 Teva Pharmaceuticals Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Teva Pharmaceuticals Peptic Ulcer Drugs Product Description
    • 11.4.5 Teva Pharmaceuticals Related Developments
  • 11.5 EA Pharma
    • 11.5.1 EA Pharma Corporation Information
    • 11.5.2 EA Pharma Overview
    • 11.5.3 EA Pharma Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 EA Pharma Peptic Ulcer Drugs Product Description
    • 11.5.5 EA Pharma Related Developments
  • 11.6 ASK Pharm
    • 11.6.1 ASK Pharm Corporation Information
    • 11.6.2 ASK Pharm Overview
    • 11.6.3 ASK Pharm Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 ASK Pharm Peptic Ulcer Drugs Product Description
    • 11.6.5 ASK Pharm Related Developments
  • 11.7 Luoxin Pharmaceutical
    • 11.7.1 Luoxin Pharmaceutical Corporation Information
    • 11.7.2 Luoxin Pharmaceutical Overview
    • 11.7.3 Luoxin Pharmaceutical Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Luoxin Pharmaceutical Peptic Ulcer Drugs Product Description
    • 11.7.5 Luoxin Pharmaceutical Related Developments
  • 11.8 Abbott Laboratories
    • 11.8.1 Abbott Laboratories Corporation Information
    • 11.8.2 Abbott Laboratories Overview
    • 11.8.3 Abbott Laboratories Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Abbott Laboratories Peptic Ulcer Drugs Product Description
    • 11.8.5 Abbott Laboratories Related Developments
  • 11.9 Yuhan Pharmaceutical
    • 11.9.1 Yuhan Pharmaceutical Corporation Information
    • 11.9.2 Yuhan Pharmaceutical Overview
    • 11.9.3 Yuhan Pharmaceutical Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Yuhan Pharmaceutical Peptic Ulcer Drugs Product Description
    • 11.9.5 Yuhan Pharmaceutical Related Developments
  • 11.10 Daewoong Pharmaceutical
    • 11.10.1 Daewoong Pharmaceutical Corporation Information
    • 11.10.2 Daewoong Pharmaceutical Overview
    • 11.10.3 Daewoong Pharmaceutical Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Daewoong Pharmaceutical Peptic Ulcer Drugs Product Description
    • 11.10.5 Daewoong Pharmaceutical Related Developments
  • 11.1 Takeda Pharmaceutical
    • 11.1.1 Takeda Pharmaceutical Corporation Information
    • 11.1.2 Takeda Pharmaceutical Overview
    • 11.1.3 Takeda Pharmaceutical Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Takeda Pharmaceutical Peptic Ulcer Drugs Product Description
    • 11.1.5 Takeda Pharmaceutical Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Peptic Ulcer Drugs Value Chain Analysis
  • 12.2 Peptic Ulcer Drugs Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Peptic Ulcer Drugs Production Mode & Process
  • 12.4 Peptic Ulcer Drugs Sales and Marketing
    • 12.4.1 Peptic Ulcer Drugs Sales Channels
    • 12.4.2 Peptic Ulcer Drugs Distributors
  • 12.5 Peptic Ulcer Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Peptic Ulcer Drugs Industry Trends
  • 13.2 Peptic Ulcer Drugs Market Drivers
  • 13.3 Peptic Ulcer Drugs Market Challenges
  • 13.4 Peptic Ulcer Drugs Market Restraints

14 Key Findings in The Global Peptic Ulcer Drugs Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Peptic Ulcer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptic Ulcer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Proton Pump Inhibitors
    Antacids
    H2-Antagonists
    Others
    Proton pump inhibitors segment was estimated to account for a revenue share of 75.6% in 2019.

    Segment by Application
    Hospital and Clinic
    Drugstore
    Hospital and clinic segment was estimated to account for a sales share of 75.7% in 2019.

    By Company
    Takeda Pharmaceutical
    AstraZeneca
    Pfizer
    Teva Pharmaceuticals
    EA Pharma
    ASK Pharm
    Luoxin Pharmaceutical
    Abbott Laboratories
    Yuhan Pharmaceutical
    Daewoong Pharmaceutical

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now